(Q71938943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Blockade of the Glucocorticoid Receptor with RU 486: Effects In Vitro and In Vivo on Human Adipose Tissue Lipoprotein Lipase Activity (English)

1 reference

Crossref

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

19 June 2024

Björntorp P

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

K. Karason

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627771

19 June 2024

M. Ottosson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627771

19 June 2024

P. Mårin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627771

19 June 2024

A. Elander

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627771

19 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7627771

19 June 2024

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1550-8528.1995.tb00143.x

1 reference

Crossref

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

https://onlinelibrary.wiley.com/doi/pdf/10.1002/j.1550-8528.1995.tb00143.x

19 June 2024

1 reference

Crossref

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

19 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

233-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Peripheral antiglucocorticoid action of RU 486 in man

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Visceral obesity: a "civilization syndrome".

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Levels of the antiprogestin RU 486 and its metabolites in human blood and follicular fluid following oral administration of a single dose

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

RU 486 inhibits peripheral effects of glucocorticoids in humans

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Dose-response relationships of RU 486.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Plasma concentrations and receptor binding of RU 486 and its metabolites in humans

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Permissive action of glucocorticoids on catecholamine-induced lipolysis: direct "in vitro" effects on the fat cell beta-adrenoreceptor-coupled-adenylate cyclase system

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Molecular mechanism of RU 486 action: a review

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Steroid hormone receptors in human adipose tissues

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Glucocorticoid hormone binding to human adipose tissue

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action

19 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1550-8528.1995.TB00143.X

19 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627771%20AND%20SRC:MED&resulttype=core&format=json